Ratio of gross profit to sales for public limited companies in the pharmaceutical industry for the 2014 to 2015 fiscal year

Annual · percent · 2012–2014 · Published by India — Reserve Bank of India

Latest · 2014

25.9%

up +1.3 pts vs 2013

High since 2012
28.3% · 2012
Low since 2012
24.6% · 2013

percent

Use this series in your AI

Use FactIQ to chart rbi::rbi|04a6b0cca48b1c0d over the last ten years, with its latest value and the change over the past year.

Paste into an AI model with FactIQ connected. How to connect

About this series

This series represents the ratio of gross profit, also known as earnings before interest and taxes (EBIT), to total sales for non-government non-financial public limited companies within the pharmaceutical industry. The data is based on historical records from the 2014-15 fiscal year and is part of the Reserve Bank of India's financial ratio analysis for select industries. (Footnote: *=actual ratio; ^=average assets; **=profit-making-company subset; @=two-year-difference derived metric; # and -=missing token)

Series ID
rbi::rbi|04a6b0cca48b1c0d
Frequency
Annual
Units
percent
Coverage
2012 – 2014
Ratio of gross profit to sales for public limited companies in the pharmaceutical industry for the 2014 to 2015 fiscal year: 25.9% for 2014 · FactIQ